Cardiogenic shock in women: From risk factors to therapy

Sigrun Halvorsen1,2, Christian Hassager3,4

  • 1Department of Cardiology, Oslo University Hospital Ullevaal, Oslo, Norway. sigrun.halvorsen@medisin.uio.no.

Kardiologia Polska
|December 31, 2024
PubMed

Insights

Cardiogenic shock (CS) in women, often non-ischemic, has high mortality. Women receive less evidence-based therapy, highlighting the need for increased awareness, timely diagnosis, and tailored management strategies for this critical cardiovascular event.

Area of Science:

  • Cardiology
  • Women's Cardiovascular Health

Background:

  • Cardiogenic shock (CS) in women presents a significant cardiovascular challenge with high mortality rates.
  • Non-ischemic causes, including stress-induced cardiomyopathy and peripartum cardiomyopathy, are prevalent in women, though acute myocardial infarction remains a critical consideration.

Purpose of the Study:

  • To provide an overview of the etiology, risk factors, diagnosis, and treatment of cardiogenic shock specifically in women.
  • To address the need for increased awareness and improved management strategies for CS in the female population.

Main Methods:

  • Review of current literature and registry data on cardiogenic shock in women.
  • Analysis of etiological factors, diagnostic approaches, and treatment modalities, including mechanical circulatory support.

Main Results:

  • Women with CS are underrepresented in clinical trials and less likely to receive guideline-recommended therapies compared to men.
  • Optimal management, particularly the role of mechanical circulatory support, requires further investigation in women.

Conclusions:

  • There is a critical need for greater awareness and timely diagnosis of CS in women.
  • Further research and robust data are essential to optimize the treatment and outcomes for women experiencing cardiogenic shock.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
717
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
515
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.8K
Imbalances in Cardiac Output01:23

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.1K